MedPath

Cognitive Rehabilitation in Alzheimer's Disease

Not Applicable
Conditions
Alzheimer's Disease
Interventions
Behavioral: cognitive rehabilitation
Behavioral: standardized cognitive training
Registration Number
NCT02247180
Lead Sponsor
University of Rostock
Brief Summary

This study aims to proof the efficacy of a cognitive rehabilitation program for patients with mild dementia in Alzheimers Disease with respect to activities of daily living.

Detailed Description

This prospective randomized, single blind intervention study aims to proof a cognitive rehabilitation program for patients with mild dementia in Alzheimers Disease (AD). The investigators modified a manualized and established German behavioural therapy program (KORDIAL) to use in a group context. The respective modules contain multimodal and multiprofessional approaches to improve capabilities relevant to activities of daily living (external memory support, compensation strategies, training of everyday competence, communication training). The intervention group receives this therapy for 12 weeks. Age and gender matched participants with AD serve as active control sample receiving a standardized cognitive training in the domesticity. The primary outcome are measurements of skills in activities of daily living prior the intervention as well as at the end of the intervention (after 3 months) and after 6 months (Follow up).

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
14
Inclusion Criteria
  • mild dementia in Alzheimer's disease (NINCDS-ADRDA)
  • Mini Mental State ≥ 17
Exclusion Criteria
  • severe psychiatric disorder
  • severe brain disorder (epilepsy, tumor, stroke)
  • contraindication for MRI examination

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Cognitive Rehabilitationcognitive rehabilitationcognitive rehabilitation for 12 weeks
Cognitive Trainingstandardized cognitive trainingstandardized cognitive training in the domesticity
Primary Outcome Measures
NameTimeMethod
Change from baseline in activities of daily living measured by a test for action regulation and planning skills (HOTAP) to the end of intervention and to follow-up (6 months later)prior intervention, after intervention (3 months), after 6 months
Change from baseline in activities of daily living measured by an ADL-scale (Bayer-ADL) to the end of intervention and to follow-up (6 months later)prior intervention, after intervention (3 months), after 6 months
Change from baseline in behavioural memory abilities measured by a behavioural memory test (RBMT) to the end of intervention and to follow-up (6 months later)prior intervention, after intervention (3 months), after 6 months
Secondary Outcome Measures
NameTimeMethod
Change from baseline in general cognitive state measured by the Consortium to Establish a Registry for Alzheimer´s Disease (CERAD) to the end of intervention and to follow-up (6 months later)prior intervention, after intervention (3 months), after 6 months
Change from baseline in structural and functional connectivity of the brain measured by MRI to the end of intervention and to follow-up (6 months later)prior intervention, after intervention (3 months), after 6 months
Change from baseline in depression and quality of life measured by two scales (GDS, DEMQoL) to the end of intervention and to follow-up (6 months later)prior intervention, after intervention (3 months), after 6 months

Trial Locations

Locations (1)

Department of Psychosomatic Medicine, University of Rostock

🇩🇪

Rostock, Germany

© Copyright 2025. All Rights Reserved by MedPath